Insulet (PODD) Interest & Investment Income (2010 - 2026)
Insulet (PODD) reported Interest & Investment Income of $4.9 million for Q1 2026, down 52.43% on a YoY basis from $10.3 million in Q1 2025, and down 14.04% quarter-over-quarter from $5.7 million in Q4 2025.
Insulet (PODD) Interest & Investment Income (2010 - 2026) Analysis & Trends
Insulet has reported Interest & Investment Income for 11 years, with the latest figure at $4.9 million in Q1 2026.
- For the quarter ending Q1 2026, Interest & Investment Income fell 52.43% year-over-year to $4.9 million; the trailing twelve-month figure through Mar 2026 stood at $29.3 million (down 27.48% YoY), and the FY2025 full-year result was $34.7 million, down 12.15% from the prior year.
- Interest & Investment Income for Q1 2026 stood at $4.9 million, down from $5.7 million in the prior quarter.
- The five-year high for Interest & Investment Income was $10.5 million in Q3 2024, with the low at $2.4 million in Q3 2022.
- Historically, Interest & Investment Income has averaged $7.7 million across 5 years, with a median of $8.6 million in 2023.
- Annual changes were most pronounced in 2023 — Interest & Investment Income jumped 258.33% — and 2026, when it plunged 52.43%.
- Insulet's Interest & Investment Income stood at $6.0 million in 2022, then advanced by 3.33% to $6.2 million in 2023, then surged by 66.13% to $10.3 million in 2024, then sank by 44.66% to $5.7 million in 2025, then decreased by 14.04% to $4.9 million in 2026.
- The last three Interest & Investment Income figures came in at $4.9 million (Q1 2026), $5.7 million (Q4 2025), and $8.6 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Int & Inv Inc (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 154.42 Bn | 147.76 Bn | 6.27 Bn | 106.00 Mn |
| 2 | Stryker | 118.12 Bn | 115.25 Bn | 3.81 Bn | - |
| 3 | Medtronic | 101.72 Bn | 93.55 Bn | 5.76 Bn | - |
| 4 | Boston Scientific | 67.19 Bn | 65.98 Bn | 3.61 Bn | - |
| 5 | Edwards Lifesciences | 50.69 Bn | 47.02 Bn | 1.29 Bn | 33.50 Mn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | 40.98 Mn |
| 7 | Dexcom | 28.09 Bn | 26.97 Bn | 750.30 Mn | - |
| 8 | GE HealthCare Technologies | 28.08 Bn | 26.02 Bn | 1.98 Bn | - |
| 9 | Steris | 19.80 Bn | 19.37 Bn | 697.10 Mn | - |
| 10 | Insulet | 10.20 Bn | 9.72 Bn | 529.10 Mn | 4.90 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 4.90 Mn |
| Dec 31, 2025 | 5.70 Mn |
| Sep 30, 2025 | 8.60 Mn |
| Jun 30, 2025 | 10.10 Mn |
| Mar 31, 2025 | 10.30 Mn |
| Dec 31, 2024 | 10.30 Mn |
| Sep 30, 2024 | 10.50 Mn |
| Jun 30, 2024 | 9.30 Mn |
| Mar 31, 2024 | 9.40 Mn |
| Dec 31, 2023 | 6.20 Mn |
| Sep 30, 2023 | 8.60 Mn |
| Jun 30, 2023 | 7.30 Mn |
| Mar 31, 2023 | 6.50 Mn |
| Dec 31, 2022 | 6.00 Mn |
| Sep 30, 2022 | 2.40 Mn |
| Sep 30, 2015 | 46,000.00 |
| Jun 30, 2015 | 41,000.00 |
| Mar 31, 2015 | 36,000.00 |
| Dec 31, 2014 | 37,000.00 |
| Sep 30, 2014 | 32,000.00 |